Phosphatidylinositol (PI) Signaling Role in Ephitelial / Mesenchymal Transition

磷脂酰肌醇 (PI) 在上皮/间质转化中的信号作用

基本信息

  • 批准号:
    7393089
  • 负责人:
  • 金额:
    $ 28.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-02 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Adhesion of cells to the extracellular matrix, formation of E-cadherin cell-cell contacts, and endocytosis-mediated regulation of plasma membrane receptors are all required for proper cell function. Dysregulation of these processes is associated with epithelial/mesenchymal transition (EMT), a key event in cancer initiation and progression. Phosphatidylinositol 4,5 bisphosphate (PI4,5P2) is a key regulator of these processes. Production of PI4,5P2 at discrete subcellular sites is mediated by the unique targeting of phosphatidylinositol phosphate kinases. Type Igamma PIP Kinase (PIPKIgamma) is positioned to mediate focal adhesion assembly, endocytosis, and maintenance of cell-cell contacts by virtue of its specific targeting to these subcellular locations and its interaction with key components and regulation by key signaling pathways. We propose to elucidate the role of PIPKI( in these processes, thus providing insight into EMT and cancer initiation and metastasis. The proposed work will critically assess this hypothesis with the following Specific Aims: (1) Determine the mechanism for PIPKIgamma targeting to cell-cell contacts via its interaction with E-cadherin and how this targeting influences EMT; (2) Investigate the role of PIPKI( in endocytosis via its interaction with the mu-subunits of the adaptor protein (AP) complexes and how this function relates to maintenance of cell-cell contacts; (3) Investigate signals that lead to Src phosphorylation of PIPKIgamma as a mechanism for regulation of E-cadherin and AP2 functions. Collective understanding of PIPKIgamma's role in each of these processes will provide insight into the mechanism of EMT and subsequent cancer metastasis. A role for PIPKIgamma in the assembly of E-cadherin cell-cell junctions, the internalization of cadherins, and signaling mechanisms that modulate EMT have many implications for cancer. Cancers of epithelial cell origin represent approximarely 80% of all cancers, and of these the loss of surface expression of E-cadherin is a prognosticator of poor patient outcome. An understanding of the underlying mechanism of E-cadherin internalization has the potential to impact our understanding of cancers of epithelial origin.
描述(由申请人提供):细胞对细胞外基质的粘附,E-钙粘蛋白细胞 - 细胞接触的形成以及内吞作用介导的质膜受体的调节都是正确的细胞功能。 这些过程的失调与上皮/间质转变(EMT)有关,这是癌症起步和进展的关键事件。 磷脂酰肌醇4,5双磷酸(PI4,5P2)是这些过程的关键调节剂。 在离散亚细胞位点生产Pi4,5p2是由磷脂酰肌醇磷酸激酶的独特靶向介导的。 Igamma型激酶(PIPKIGAMMA)定位可介导局灶性粘附组件,内吞作用,并通过其特异性靶向这些亚细胞位置的特定靶向细胞 - 细胞接触,并通过关键信号通路与关键成分和调节。 我们建议阐明Pipki的作用(在这些过程中,从而提供了对EMT,癌症的起始和转移的见解。拟议的工作将以以下具体目的对这一假设进行批判性评估:(1)确定PIPKIGAMMA靶向与细胞细胞接触的机制,通过与e-Cadherin和pocting tage taking(2)(2)(2)(2)(2)(2)(2)(2)(2)(2)(2)(2)(2)(2)与适配器蛋白(AP)复合物的MU-支出相互作用,以及该功能如何与细胞 - 细胞接触的维持有关;(3)调查导致PIPKIGAMMA的SRC磷酸化的信号,以此作为调节E-Cadherin和Ap2功能的调节的机制。 Pipkigamma在E-钙粘蛋白细胞 - 细胞连接的组装中的作用,钙粘蛋白的内在化以及调节EMT的信号传导机制对癌症具有许多影响。 上皮细胞起源的癌症大约占所有癌症的80%,在这些癌症中,e-钙粘着蛋白的表面表达丧失是患者预后不良的预后。 对电子钙粘蛋白内在化的潜在机制的理解有可能影响我们对上皮癌症的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard A. Anderson其他文献

Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
在临床试验中测量卵巢毒性:美国临床肿瘤学会研究声明。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    W. Cui;R. Rocconi;Ramya Thota;Richard A. Anderson;S. Bruinooge;Ioanna A Comstock;N. Denduluri;Audrey Gassman;Julie R Gralow;Karla J. Hutt;L. Amiri;M. Lambertini;John K Leighton;Karen H Lu;S. Mostoufi;Teri Pollastro;Shan Pradhan;H. Saber;Caroline Schenkel;D. Spratt;S. Wedam;K. Phillips
  • 通讯作者:
    K. Phillips
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton.
蛋白质 4.1 和带 3 之间的相互作用。膜骨架元件的替代结合位点。
  • DOI:
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Gary R. PasternackS;Richard A. Anderson;Thomas L. Leto;Vincent T. Marchesi
  • 通讯作者:
    Vincent T. Marchesi
Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
性腺功能减退男性中合成雄激素 7 α-甲基-19-去甲睾酮的组织选择性的证据。
FROM THIENOPYRIDINES TO NITROSOTHIOLS: A NOVEL POTENTIAL MECHANISM OF THIENOPYRIDINES BIOACTIVITY
  • DOI:
    10.1016/s0735-1097(11)61918-9
  • 发表时间:
    2011-04-05
  • 期刊:
  • 影响因子:
  • 作者:
    Richard A. Anderson;Shantu Bundhoo;Ewelina Sagan;Jessica Dada;Rebecca Harris;Phillip James
  • 通讯作者:
    Phillip James
Effects of chromium and resistive training on muscle strength and body composition.
铬和阻力训练对肌肉力量和身体成分的影响。
  • DOI:
    10.1097/00005768-199601000-00025
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Melissa A. Hallmark;Thomas H. Reynolds;Christopher A. DeSouza;Charles O. Dotson;Richard A. Anderson;Marc A. Rogers
  • 通讯作者:
    Marc A. Rogers

Richard A. Anderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard A. Anderson', 18)}}的其他基金

Tau-PI3Kalpha Complex in Regulation of PI3K/Akt-dependent Neuronal Function and Survival
Tau-PI3Kalpha 复合物调节 PI3K/Akt 依赖性神经元功能和存活
  • 批准号:
    10710161
  • 财政年份:
    2022
  • 资助金额:
    $ 28.28万
  • 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
  • 批准号:
    10386086
  • 财政年份:
    2020
  • 资助金额:
    $ 28.28万
  • 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
  • 批准号:
    10323007
  • 财政年份:
    2020
  • 资助金额:
    $ 28.28万
  • 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
  • 批准号:
    10077869
  • 财政年份:
    2020
  • 资助金额:
    $ 28.28万
  • 项目类别:
Administrative Supplement: Phosphoinositide Signaling in the Cytosol and Nucleus
行政补充:细胞质和细胞核中的磷酸肌醇信号传导
  • 批准号:
    10799130
  • 财政年份:
    2020
  • 资助金额:
    $ 28.28万
  • 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
  • 批准号:
    10561701
  • 财政年份:
    2020
  • 资助金额:
    $ 28.28万
  • 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
  • 批准号:
    9027153
  • 财政年份:
    2015
  • 资助金额:
    $ 28.28万
  • 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
  • 批准号:
    9199104
  • 财政年份:
    2015
  • 资助金额:
    $ 28.28万
  • 项目类别:
Phosphoinositide Signaling To and Within the Nucleus
进入细胞核和细胞核内的磷酸肌醇信号传导
  • 批准号:
    8059297
  • 财政年份:
    2010
  • 资助金额:
    $ 28.28万
  • 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
  • 批准号:
    7892114
  • 财政年份:
    2009
  • 资助金额:
    $ 28.28万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
ROS Signaling in Wound Healing vs Tissue Repair
伤口愈合与组织修复中的 ROS 信号传导
  • 批准号:
    10654242
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
  • 批准号:
    10646015
  • 财政年份:
    2023
  • 资助金额:
    $ 28.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了